Medpace Holdings, Inc. (MEDP) vs NVIDIA Corporation (NVDA)
A side-by-side comparison of Medpace Holdings, Inc. and NVIDIA Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.
Different business models: MEDP is classified in Healthcare; NVDA is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
MEDP
Medpace Holdings, Inc.
$587.52HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
NVDA
NVIDIA Corporation
$218.29TechnologyDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — MEDP vs NVDA
growth of $100 · dividends reinvested · last 10yMEDP +1860.2% (+34.7%/yr)NVDA +14538.6% (+64.6%/yr)NVDA compounded faster over this window
Log scale — wide-divergence pair
MEDP NVDA
MEDP vs NVDA: by the numbers
- •NVDA is the larger company ($5.29T vs $16.40B market cap).
- •NVDA trades at the lower trailing earnings multiple (27.60 vs 34.42 P/E), one valuation lens rather than an overall verdict.
- •NVDA converts more revenue to profit (63.66% vs 17.67% net margin).
- •NVDA grew revenue faster over the past five years (69.34% vs 22.03% CAGR).
- •NVDA pays a dividend (0.13% yield), while MEDP has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | MEDP | NVDA |
|---|---|---|
| P/E ratio | 34.42 | 27.60 |
| Forward P/E | 33.38 | 23.59 |
| P/S ratio | 5.89 | 17.45 |
| P/B ratio | 37.80 | 23.09 |
| EV / EBITDA | 26.20 | 26.35 |
| FCF yield | 4.28% | 2.40% |
Profitability
| Metric | MEDP | NVDA |
|---|---|---|
| Gross margin | 28.76% | 74.67% |
| Operating margin | 20.97% | 65.21% |
| Net margin | 17.67% | 63.66% |
| ROE | 113.29% | 84.23% |
| ROIC | 77.00% | 59.61% |
Dividends
| Metric | MEDP | NVDA |
|---|---|---|
| Dividend yield | N/A | 0.13% |
| Payout ratio | N/A | 3.54% |
Growth (annualized)
| Metric | MEDP | NVDA |
|---|---|---|
| Revenue CAGR (5Y) | 22.03% | 69.34% |
| EPS CAGR (5Y) | 30.90% | 94.31% |
| FCF CAGR (5Y) | 23.40% | 82.12% |
| Total return CAGR (5Y) | 24.92% | 57.72% |
Frequently asked
- Which has the lower trailing P/E, MEDP or NVDA?
- NVDA has the lower trailing P/E: MEDP trades at 34.42 and NVDA at 27.60. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, MEDP or NVDA?
- Over the past five years, NVDA grew revenue faster — MEDP at a 22.03% CAGR versus NVDA at 69.34%.
- Does MEDP or NVDA pay a bigger dividend?
- NVDA pays a dividend (0.13% yield), while MEDP has no payments in the available dividend history.
- Is MEDP or NVDA more profitable?
- NVDA runs the higher net margin — MEDP at 17.67% versus NVDA at 63.66%.
- How have MEDP and NVDA total returns compared?
- Over the past 10 years, MEDP delivered 34.74% and NVDA delivered 64.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Medpace P/E ratioNVIDIA P/E ratioNVIDIA dividend yieldMedpace ROENVIDIA ROEMedpace operating marginNVIDIA operating marginMedpace revenue growthNVIDIA revenue growthMedpace free cash flowNVIDIA free cash flow
Medpace & NVIDIA appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.